These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 21730142)

  • 1. Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters.
    Andersen J; Stuhr-Hansen N; Zachariassen L; Toubro S; Hansen SM; Eildal JN; Bond AD; Bøgesø KP; Bang-Andersen B; Kristensen AS; Strømgaard K
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12137-42. PubMed ID: 21730142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket.
    Sørensen L; Andersen J; Thomsen M; Hansen SM; Zhao X; Sandelin A; Strømgaard K; Kristensen AS
    J Biol Chem; 2012 Dec; 287(52):43694-707. PubMed ID: 23086945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for selective serotonin reuptake inhibition by the antidepressant agent fluoxetine (Prozac).
    Andersen J; Stuhr-Hansen N; Zachariassen LG; Koldsø H; Schiøtt B; Strømgaard K; Kristensen AS
    Mol Pharmacol; 2014 May; 85(5):703-14. PubMed ID: 24516100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter.
    Andersen J; Olsen L; Hansen KB; Taboureau O; Jørgensen FS; Jørgensen AM; Bang-Andersen B; Egebjerg J; Strømgaard K; Kristensen AS
    J Biol Chem; 2010 Jan; 285(3):2051-63. PubMed ID: 19892699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the 5-HT transporter.
    Larsen MA; Plenge P; Andersen J; Eildal JN; Kristensen AS; Bøgesø KP; Gether U; Strømgaard K; Bang-Andersen B; Loland CJ
    Br J Pharmacol; 2016 Mar; 173(5):925-36. PubMed ID: 26699847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding site residues control inhibitor selectivity in the human norepinephrine transporter but not in the human dopamine transporter.
    Andersen J; Ringsted KB; Bang-Andersen B; Strømgaard K; Kristensen AS
    Sci Rep; 2015 Oct; 5():15650. PubMed ID: 26503701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putative drug binding conformations of monoamine transporters.
    Ravna AW; Sylte I; Kristiansen K; Dahl SG
    Bioorg Med Chem; 2006 Feb; 14(3):666-75. PubMed ID: 16216517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.
    Eildal JN; Andersen J; Kristensen AS; Jørgensen AM; Bang-Andersen B; Jørgensen M; Strømgaard K
    J Med Chem; 2008 May; 51(10):3045-8. PubMed ID: 18429609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters.
    Andersen J; Kristensen AS; Bang-Andersen B; Strømgaard K
    Chem Commun (Camb); 2009 Jul; (25):3677-92. PubMed ID: 19557250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.
    Ravna AW; Sylte I; Dahl SG
    J Pharmacol Exp Ther; 2003 Oct; 307(1):34-41. PubMed ID: 12944499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of structural elements for selectivity across monoamine transporters: novel 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues.
    Okunola-Bakare OM; Cao J; Kopajtic T; Katz JL; Loland CJ; Shi L; Newman AH
    J Med Chem; 2014 Feb; 57(3):1000-13. PubMed ID: 24494745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of the Extracellular Loop 4 in the Human Serotonin Transporter for Inhibitor Binding and Substrate Translocation.
    Rannversson H; Wilson P; Kristensen KB; Sinning S; Kristensen AS; Strømgaard K; Andersen J
    J Biol Chem; 2015 Jun; 290(23):14582-94. PubMed ID: 25903124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [(3)H] citalopram binding to serotonin transporter sites in minnow brains.
    Gould GG; Brooks BW; Frazer A
    Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):203-10. PubMed ID: 17697042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular loop 3 of the noradrenaline transporter contributes to substrate and inhibitor selectivity.
    Lynagh T; Khamu TS; Bryan-Lluka LJ
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jan; 387(1):95-107. PubMed ID: 24081522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrogating the Molecular Basis for Substrate Recognition in Serotonin and Dopamine Transporters with High-Affinity Substrate-Based Bivalent Ligands.
    Andersen J; Ladefoged LK; Kristensen TN; Munro L; Grouleff J; Stuhr-Hansen N; Kristensen AS; Schiøtt B; Strømgaard K
    ACS Chem Neurosci; 2016 Oct; 7(10):1406-1417. PubMed ID: 27425420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships for a novel series of citalopram (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile) analogues at monoamine transporters.
    Zhang P; Cyriac G; Kopajtic T; Zhao Y; Javitch JA; Katz JL; Newman AH
    J Med Chem; 2010 Aug; 53(16):6112-21. PubMed ID: 20672825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.
    Henry LK; Field JR; Adkins EM; Parnas ML; Vaughan RA; Zou MF; Newman AH; Blakely RD
    J Biol Chem; 2006 Jan; 281(4):2012-23. PubMed ID: 16272152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further structure-activity relationship studies of piperidine-based monoamine transporter inhibitors: effects of piperidine ring stereochemistry on potency. Identification of norepinephrine transporter selective ligands and broad-spectrum transporter inhibitors.
    He R; Kurome T; Giberson KM; Johnson KM; Kozikowski AP
    J Med Chem; 2005 Dec; 48(25):7970-9. PubMed ID: 16335921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
    Zhao Z; Zhang HT; Bootzin E; Millan MJ; O'Donnell JM
    Neuropsychopharmacology; 2009 May; 34(6):1467-81. PubMed ID: 18923402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study.
    Takano A; Halldin C; Farde L
    Psychopharmacology (Berl); 2013 Mar; 226(1):147-53. PubMed ID: 23090625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.